BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1390832)

  • 1. Hexose-specific inhibition in vitro of human red cell Ca(2+)-ATPase activity.
    Deziel MR; Safeer RS; Blas SD; Davis FB; Davis PJ
    Biochim Biophys Acta; 1992 Sep; 1110(1):119-22. PubMed ID: 1390832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inositol phosphates inhibit basal and calmodulin-stimulated Ca(2+)-ATPase activity in human erythrocyte membranes in vitro and inhibit binding of calmodulin to membranes.
    Davis FB; Davis PJ; Lawrence WD; Blas SD
    FASEB J; 1991 Nov; 5(14):2992-5. PubMed ID: 1836436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The erythrocyte calcium pump is inhibited by non-enzymic glycation: studies in situ and with the purified enzyme.
    González Flecha FL; Castello PR; Caride AJ; Gagliardino JJ; Rossi JP
    Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):369-75. PubMed ID: 8393658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of long-chain fatty acids in vitro on Ca2+-stimulatable, Mg2+-dependent ATPase activity in human red cell membranes.
    Davis FB; Davis PJ; Blas SD; Schoenl M
    Biochem J; 1987 Dec; 248(2):511-6. PubMed ID: 2963620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cholera toxin on human red cell Ca-ATPase.
    Romero PJ; Weitzman C
    Biochem Biophys Res Commun; 1991 Nov; 181(1):208-12. PubMed ID: 1835576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the Ca pump ATPase of human red blood cell membranes by dithio compounds.
    Vincenzi FF; Wu L
    Proc West Pharmacol Soc; 1988; 31():231-3. PubMed ID: 2974990
    [No Abstract]   [Full Text] [Related]  

  • 7. Diamide inhibited (Ca++ + Mg++) and (Mg++) dependent ATPase in erythrocyte membranes: activity at different temperatures.
    Scutari G; Ballestrin G; Covaz L
    Boll Soc Ital Biol Sper; 1979 Jul; 55(13):1283-7. PubMed ID: 159703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of plasma membrane Ca(2+)-ATPase activity by volatile anesthetics.
    Kosk-Kosicka D; Roszczynska G
    Anesthesiology; 1993 Oct; 79(4):774-80. PubMed ID: 8214757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of retinoids as inhibitors of calmodulin-dependent human erythrocyte Ca(2+)-ATPase activity and calmodulin binding to membranes.
    Davis FB; Smith TJ; Davis PJ; Blas SD
    Biochem J; 1991 Aug; 277 ( Pt 3)(Pt 3):603-6. PubMed ID: 1831350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of the glycated plasma membrane calcium pump.
    González Flecha FL; Castello PR; Gagliardino JJ; Rossi JP
    J Membr Biol; 1999 Sep; 171(1):25-34. PubMed ID: 10485991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of in vivo glucose administration on human erythrocyte Ca2+-ATPase activity and on enzyme responsiveness in vitro to thyroid hormone and calmodulin.
    Davis FB; Davis PJ; Nat G; Blas SD; MacGillivray M; Gutman S; Feldman MJ
    Diabetes; 1985 Jul; 34(7):639-46. PubMed ID: 2989051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-competitive inhibition of myo-inositol transport in cultured bovine retinal capillary pericytes by glucose and reversal by Sorbinil.
    Li W; Chan LS; Khatami M; Rockey JH
    Biochim Biophys Acta; 1986 May; 857(2):198-208. PubMed ID: 3085711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protein inhibitor of erythrocyte membrane (Ca2+ + Mg2+)-ATPase.
    Lee KS; Au KS
    Biochim Biophys Acta; 1983 Jan; 742(1):54-62. PubMed ID: 6130792
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of red cell Ca2+-ATPase by vanadate.
    Bond GH; Hudgins PM
    Biochim Biophys Acta; 1980 Aug; 600(3):781-90. PubMed ID: 6447513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+-mediated activation of human erythrocyte membrane Ca2+-ATPase.
    Au KS; Lee MF; Siu YL
    Biochim Biophys Acta; 1989 Jan; 978(2):197-202. PubMed ID: 2536555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor age-dependent decline in response of human red cell Ca2+-ATPase activity to thyroid hormone in vitro.
    Davis PJ; Davis FB; Blas SD; Schoenl M; Edwards L
    J Clin Endocrinol Metab; 1987 May; 64(5):921-5. PubMed ID: 3031121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the erythrocyte (Ca2+ + Mg2+)-ATPase by nonheme iron.
    Leclerc L; Marden M; Poyart C
    Biochim Biophys Acta; 1991 Feb; 1062(1):35-8. PubMed ID: 1825610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effects of cyproheptadine on calmodulin activated Ca(2+)-ATPase activity of rabbit erythrocyte membranes].
    Xin HB; Zhang BH
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14 Suppl():S5-7. PubMed ID: 8010076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the calmodulin-dependent regulation of calcium adenosine triphosphatase of erythrocyte membranes in patients with ischemic heart disease].
    Malaia LT; Petruniaka VV; Rudyk IuS
    Vestn Akad Med Nauk SSSR; 1991; (7):54-8. PubMed ID: 1838226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target sizes of human erythrocyte membrane Ca2+-ATPase and Mg2+-ATPase activities in the presence and absence of calmodulin.
    Hymel L; Nielsen M; Gietzen K
    Biochim Biophys Acta; 1985 May; 815(3):461-7. PubMed ID: 3158352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.